{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:03:02Z","timestamp":1772751782046,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.vaccine.2004.10.021","type":"journal-article","created":{"date-parts":[[2004,11,13]],"date-time":"2004-11-13T16:59:21Z","timestamp":1100365161000},"page":"1887-1899","source":"Crossref","is-referenced-by-count":39,"title":["Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135"],"prefix":"10.1016","volume":"23","author":[{"given":"Angela","family":"Bardotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Averani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Ravenscroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.10.021_bib1","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease","volume":"359","author":"Jodar","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2004.10.021_bib2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0264-410X(01)00410-8","article-title":"Vaccine prevention of meningococcal disease, coming soon?","volume":"20","author":"Morley","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2004.10.021_bib3","first-page":"259","article-title":"Meningococcal disease","volume":"23","author":"Memish","year":"2002","journal-title":"Saudi Med J"},{"key":"10.1016\/j.vaccine.2004.10.021_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/o76-001","article-title":"Structural determination of the polysaccharide antigens of Neisseria meningitidis serogroups Y, W135 and BO","volume":"54","author":"Bhattacharjee","year":"1976","journal-title":"Can J Biochem"},{"key":"10.1016\/j.vaccine.2004.10.021_bib5","first-page":"152","article-title":"Meningococcal vaccines: the challenge and the prospects","volume":"13","author":"Ala\u2019Aldeen","year":"1997","journal-title":"PHLS Microbiol Digest"},{"key":"10.1016\/j.vaccine.2004.10.021_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1201-9712(97)90079-5","article-title":"Meningococcal polysaccharide-protein conjugate vaccines","volume":"1","author":"Granoff","year":"1997","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.10.021_bib7","first-page":"13","article-title":"Semisynthetic vaccines against bacterial meningitis","volume":"3","author":"Costantino","year":"1990","journal-title":"Chimica Oggi"},{"key":"10.1016\/j.vaccine.2004.10.021_bib8","unstructured":"WHO Technical Report Series. Requirements for meningococcal and Haemophilus type b conjugate vaccines, 2000, 897, Annex 1,27-60."},{"key":"10.1016\/j.vaccine.2004.10.021_bib9","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0264-410X(98)00348-X","article-title":"Size fractionation of bacterial capsular oligosaccharides for their use in conjugate vaccines","volume":"17","author":"Costantino","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.10.021_bib10","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1016\/S0264-410X(99)00092-4","article-title":"Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines","volume":"17","author":"Ravenscroft","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.10.021_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1006\/abio.1997.2224","article-title":"Direct and indirect methods for molar-mass analysis of fragments of the capsular polysaccharides of Haemophilus Influenzae type b","volume":"250","author":"D\u2019Ambra","year":"1997","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.vaccine.2004.10.021_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/abio.1994.1523","article-title":"\u03b12-8 Sialic acid polymers: size, structure and compositional analysis","volume":"222","author":"Ashwell","year":"1994","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2004.10.021_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0006-3002(57)90254-8","article-title":"Quantitative estimation of sialic acid. II. A colorimetric resorcinol hydrochloric method","volume":"24","author":"Svennerholm","year":"1957","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.vaccine.2004.10.021_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0008-6215(96)00253-4","article-title":"Full 1H NMR assignments and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitides used in vaccine production","volume":"296","author":"Lemercinier","year":"1996","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2004.10.021_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0003-2697(92)90349-C","article-title":"Carbohydrate composition analysis of bacterial polysaccharides: optimized acid hydrolysis conditions for HPAEC-PAD","volume":"201","author":"Ip","year":"1992","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2004.10.021_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0003-2697(84)90516-5","article-title":"A quantitative determination by capillary gas-liquid chromatography of neutral and amino sugars (as O-methyloxime acetates), and a study on hydrolytic conditions for glycoproteins and polysaccharides in order to increase sugar recoveries","volume":"142","author":"Neeser","year":"1984","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2004.10.021_bib17","series-title":"Analysis of Carbohydrates by GLC and MS","article-title":"Hydrolysis and other cleavages of glycosidic bonds","author":"Bierman","year":"1989"},{"key":"10.1016\/j.vaccine.2004.10.021_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI115564","article-title":"Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharides-tetanus toxoid conjugates","volume":"89","author":"Paoletti","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2004.10.021_bib19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4049\/jimmunol.137.4.1181","article-title":"Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infants","volume":"137","author":"Anderson","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.10.021_bib20","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1128\/IAI.65.12.4918-4925.1997","article-title":"A strategy for rational design of fully synthetic glycopeptide conjugate vaccines","volume":"65","author":"Chong","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.10.021_bib21","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1073\/pnas.96.9.5194","article-title":"Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1","volume":"96","author":"Pozsgay","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2004.10.021_bib22","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/IAI.69.7.4698-4701.2001","article-title":"Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice","volume":"69","author":"Benaissa-Trouw","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.10.021_bib23","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0264-410X(00)00427-8","article-title":"Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection","volume":"19","author":"Ricci","year":"2001","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0400790X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0400790X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T06:19:13Z","timestamp":1682835553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0400790X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":23,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0264410X0400790X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.10.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}